ATX-559, a first-in-class oral DHX9 inhibitor, is being evaluated in a Phase 1/2 study with a focus on advanced or metastatic patients with BRCA-1 and/or BRCA-2-deficient breast cancer or MSI-H...

The Bank of New York Mellon Corporation ("BNY") (NYSE: BK), a global financial services company, today announced that Jim Crowley, Global Head of BNY Pershing, will speak at the Morgan Stanley...

Envista Holdings Corporation (NYSE: NVST) ("Envista") today announced that the company will participate in the Stifel 2025 Jaws & Paws Conference. The fireside chat will take place on Wednesday,...

Novel Anti-CD20/BCMA Bispecific Autologous CAR-T Therapy Targeting Lupus Nephritis, Systemic Lupus Erythematosus and Multiple Sclerosis Phase 1, First-in-Human Investigator-Initiated Trial (IIT)...

Lear Corporation (NYSE: LEA), a global automotive technology leader in Seating and E-Systems, will participate in a fireside chat on June 11, 2025, at the Wells Fargo Industrials and Materials...